POU1F1
protein-codingPOU class 1 homeobox 1, the group of POU class homeoboxes and pseudogenes
Gene summary
This gene encodes a member of the POU family of transcription factors that regulate mammalian development. The protein regulates expression of several genes involved in pituitary development and hormone expression. Mutations in this genes result in combined pituitary hormone deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
- PIT1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~17.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008250
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0016411
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0024464
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0024464
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0024464
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0024464
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0024464
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0024464
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013099
Submitter: Orphanet
Inheritance Pattern: SD
Disease ID:MONDO:0024464
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Endocrine
Intervention: Cardiovascular; Endocrine
Rationale: Individuals may manifest with central deficiency of multiple hormones, which can result in severe sequelae if untreated, and replacement therapy can be effective
Comments: A minority of individuals have been described with cardiac anomalies
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to POU1F1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000306.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 63 | 64 | |||
| missense | 6 | 8 | 56 | 3 | 73 | |
| nonsense | 7 | 1 | 8 | |||
| start loss | 1 | 1 | ||||
| frameshift | 8 | 3 | 11 | |||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 6 | |||
| Total | 22 | 17 | 58 | 66 | 0 | 163 |
Highest pathogenic variant AF is 0.000035949986
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000297.1 | 6 | MANE Select | |
| Ensembl | ENSP00000263781.2 | 6 | MANE Select | |
| RefSeq | NP_001116229.1 | 6 | Standard | |
| Ensembl | ENSP00000342931.3 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| pou1f1 | Danio rerio | Structure: whole organism Quality: decreased length abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glucocorticoid receptor regulatory network
Biological Process
- negative regulation of transcription by RNA polymerase II
- cell fate specification
- regulation of transcription, DNA-templated
- transcription by RNA polymerase II
- positive regulation of cell population proliferation
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II transcription factor binding
- RNA polymerase II activating transcription factor binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
Cellular Component
- chromatin
- nucleus
- transcription factor complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000344265
- Coding exons
- 6
- Length
- 17184
- Individuals with no LoFs
- 125720
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 18
- Defined
- 125738
- p
- 0.0000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.457 | 149 | 166 | 0.900 | 0.00000805 | 2075 |
| Missense (PolyPhen) | 59 | 59.433 | 0.99272 | 769 | ||
| Synonymous | -0.532 | 64 | 58.8 | 1.09 | 0.00000290 | 607 |
| Loss of Function | 2.46 | 5 | 15.4 | 0.324 | 8.93e-7 | 178 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00011 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcription factor involved in the specification of the lactotrope, somatotrope, and thyrotrope phenotypes in the developing anterior pituitary. Specifically binds to the consensus sequence 5'-TAAAT-3'. Activates growth hormone and prolactin genes (PubMed:22010633, PubMed:26612202). {ECO:0000269|PubMed:22010633, ECO:0000269|PubMed:26612202}.;
- Disease
- DISEASE: Pituitary hormone deficiency, combined, 1 (CPHD1) [MIM:613038]: Combined pituitary hormone deficiency is defined as the impaired production of growth hormone and one or more of the other five anterior pituitary hormones. CPHD1 is characterized by pleiotropic deficiencies of growth hormone, prolactin and thyroid- stimulating hormone, while the production of adrenocorticotropic hormone, luteinizing hormone, and follicle-stimulating hormone are preserved. In infancy severe growth deficiency from birth as well as distinctive facial features with prominent forehead, marked midfacial hypoplasia with depressed nasal bridge, deep-set eyes, and a short nose with anteverted nostrils and hypoplastic pituitary gland by MRI examination can be seen. Some cases present with severe mental retardation along with short stature. {ECO:0000269|PubMed:11297581, ECO:0000269|PubMed:1472057, ECO:0000269|PubMed:1509262, ECO:0000269|PubMed:1509263, ECO:0000269|PubMed:15928241, ECO:0000269|PubMed:16968807, ECO:0000269|PubMed:22010633, ECO:0000269|PubMed:26612202, ECO:0000269|PubMed:7852536, ECO:0000269|PubMed:8768831, ECO:0000269|PubMed:9485179, ECO:0000269|PubMed:9626142}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.288
Intolerance Scores
- LoFtool
- 0.231
- RVIS EVS
- 0.04
- RVIS percentile EVS
- 56.92
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.754
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |